공구 (한양대학교)님 | 한빛사연구자 > 한빛사

한양대학교

최종업데이트 2017.10.20.

Role of MEL-18 Amplification in Anti-HER2 Therapy of Breast Cancer
- JNCI-J. Natl. Cancer Inst., Published: 27 September 2018 | https://doi.org/10.1093/jnci/djy151
- 2018-09
- 의약학
- 한빛사논문
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
- JNCI-J. Natl. Cancer Inst., Volume 110, Issue 4, 1 April 2018, djx207 | https://doi.org/10.1093/jnci/djx207
- 2017-10
- 의약학
- 한빛사논문
- 공구(한양대학교)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- Nature, Published online 02 May 2016 | doi:10.1038/nature17676
- 2016-05
- 의약학
- 한빛사논문
DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression
- Nat. Commun., Published 22 July 2015 | doi:10.1038/ncomms8821
- 2015-07
- 의약학
- 한빛사논문
MEL-18 loss mediates estrogen receptor–α downregulation and hormone independence
- J. Clin. Invest., 2015;125(5):1801–1814. | doi:10.1172/JCI73743
- 2015-03
- 의약학
- 한빛사논문
A genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification
- Hepatology, Accepted manuscript online: 3 MAY 2014, DOI: 10.1002/hep.27198
- 2014-05
- 의약학
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문